Políticas Médicas
Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.
Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.
| ID | Título | Última Revisión | Siguiente Revisión | Descripción | Acceso |
|---|---|---|---|---|---|
| 08.001.036 | Allogeneic Hematopoietic Cell Transplantation | Feb 12, 2024 | Feb 20, 2025 | Allogeneic hematopoietic cell transplantation (hct) using a myeloablative conditioning regimen may be... | Ver |
| 08.001.037 | Hematopoietic Cell Transplantation for Hodgkin Lymphoma | Feb 12, 2024 | Feb 20, 2025 | Autologous hematopoietic cell transplantation (hct) may be considered medically necessary in patients with... | Ver |
| 08.001.038 | Radio 223 Injection (Xofigo) | Nov 10, 2021 | Policy Archived | The radium 223 injection (xofigo) is considered for payment when all of the following criteria for prostate... | Ver |
| 08.001.039 | Extracorporeal Membrane Oxygenation for Adult Conditions | Jun 06, 2023 | Jun 20, 2024 | The use of extracorporeal membrane oxygenation (ecmo) may be considered medically necessary for the... | Ver |
| 08.001.040 | Diagnosis and Treatment of Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis | Dec 16, 2019 | Policy Archived | The identification and subsequent treatment of chronic cerebrospinal venous insufficiency in patients with... | Ver |
| 08.001.041 | Application Of Fluoride (Varnish) | Nov 14, 2019 | Policy Archived | Fluoride varnish is considered medically necessary to help reduce the risk of decayed, missing, or filled... | Ver |
| 08.001.042 | Orthopedic Applications of Stem Cell Therapy (Including Allografts and Bone Substitutes Used With Autologous Bone Marrow) | Feb 20, 2024 | Feb 20, 2025 | Mesenchymal stem cell therapy is considered investigational for all orthopedic applications, including use in... | Ver |
| 08.001.043 | Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia | Feb 12, 2024 | Feb 20, 2025 | Childhood acute lymphoblastic leukemia autologous or allogeneic hematopoietic cell transplantation... | Ver |
| 08.001.044 | Treatment of Hyperhidrosis | Jul 18, 2023 | Jul 20, 2024 | Treatment of primary focal hyperhidrosis using aluminum chloride 20% solution, botulinum toxin for severe... | Ver |
| 08.001.045 | Cranial Electrotherapy Stimulation and Auricular Electrostimulation | Mar 15, 2024 | Mar 20, 2025 | Cranial electrotherapy stimulation (also known as cranial electrostimulation therapy) is investigational in... | Ver |
| 08.001.046 | Electronic Brachytherapy for Nonmelanoma Skin Cancer | Aug 15, 2023 | Aug 20, 2024 | Electronic brachytherapy for the treatment of nonmelanoma skin cancer is... | Ver |
| 08.001.047 | Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Feb 12, 2024 | Feb 20, 2025 | Allogeneic hematopoietic cell transplantation is considered medically necessary to treat chronic lymphocytic... | Ver |
| 08.001.048 | Hematopoietic Cell Transplantation for Non-Hodgkin Lymphomas | Feb 12, 2024 | Feb 20, 2025 | For individuals with non-hodgkin lymphoma (nhl) b-cell subtypes considered aggressive (except mantle cell... | Ver |
| 08.001.049 | Hematopoietic Cell Transplantation for Autoimmune Diseases | Feb 20, 2024 | Feb 20, 2025 | Autologous or allogeneic hematopoietic cell transplantation (hct) is considered investigational as a... | Ver |
| 08.001.050 | Hematopoietic Cell Transplantation for Acute Myeloid Leukemia | Feb 20, 2024 | Feb 20, 2025 | Allogeneic hematopoietic cell transplantation (hct) using a myeloablative conditioning regimen may be... | Ver |
| 08.001.051 | Hematopoietic cell Transplantation for Primary Amyloidosis | Feb 13, 2024 | Feb 20, 2025 | Autologous hematopoietic cell transplantation may be considered medically necessary to treat primary... | Ver |
| 08.001.052 | Intraoperative Radiotherapy | Aug 09, 2023 | Aug 20, 2024 | Use of intraoperative radiotherapy may be considered medically necessary in the following situation:... | Ver |
| 08.001.053 | Chimeric Antigen Receptor Therapy for Leukemia and Lymphoma | Jan 08, 2024 | Jan 20, 2025 | Tisagenlecleucel for b-cell acute lymphoblastic leukemia tisagenlecleucel is considered medically... | Ver |
| 08.001.054 | Hematopoietic Cell Transplantation for Waldenstrom Macroglobulinemia | Mar 19, 2021 | Policy Archived | Autologous hematopoietic cell transplantation may be considered medically necessary as salvage therapy of... | Ver |
| 08.001.056 | Intradialytic Parenteral Nutrition | Jun 12, 2023 | Jun 20, 2024 | Intradialytic parenteral nutrition as an adjunct to hemodialysis may be considered medically necessary when... | Ver |
